691 related articles for article (PubMed ID: 33439102)
1. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling.
Li SW; Takahara T; Que W; Fujino M; Guo WZ; Hirano SI; Ye LP; Li XK
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G450-G463. PubMed ID: 33439102
[TBL] [Abstract][Full Text] [Related]
2. Effects of alkaline-electrolyzed and hydrogen-rich water, in a high-fat-diet nonalcoholic fatty liver disease mouse model.
Jackson K; Dressler N; Ben-Shushan RS; Meerson A; LeBaron TW; Tamir S
World J Gastroenterol; 2018 Dec; 24(45):5095-5108. PubMed ID: 30568387
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
[TBL] [Abstract][Full Text] [Related]
4. Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.
Sodhi K; Puri N; Favero G; Stevens S; Meadows C; Abraham NG; Rezzani R; Ansinelli H; Lebovics E; Shapiro JI
PLoS One; 2015; 10(6):e0128648. PubMed ID: 26098879
[TBL] [Abstract][Full Text] [Related]
5. Molecular hydrogen protects against ischemia-reperfusion injury in a mouse fatty liver model via regulating HO-1 and Sirt1 expression.
Li S; Fujino M; Ichimaru N; Kurokawa R; Hirano S; Mou L; Takahara S; Takahara T; Li XK
Sci Rep; 2018 Sep; 8(1):14019. PubMed ID: 30232347
[TBL] [Abstract][Full Text] [Related]
6. Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression.
Ryu J; Kim E; Kang MK; Song DG; Shin EA; Lee H; Jung JW; Nam SH; Kim JE; Kim HJ; Son T; Kim S; Kim HY; Lee JW
J Pathol; 2021 Jan; 253(1):55-67. PubMed ID: 32918742
[TBL] [Abstract][Full Text] [Related]
7. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
8. Anti-oxidant and anti-inflammatory effects of hydrogen-rich water alleviate ethanol-induced fatty liver in mice.
Lin CP; Chuang WC; Lu FJ; Chen CY
World J Gastroenterol; 2017 Jul; 23(27):4920-4934. PubMed ID: 28785146
[TBL] [Abstract][Full Text] [Related]
9. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
10. [The role of heme oxygenase-1 in non-alcoholic steatohepatitis].
Wang RQ; Nan YM; Han F; Zhao SX; Fu N; Wu WJ
Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):680-4. PubMed ID: 20943080
[TBL] [Abstract][Full Text] [Related]
11. Aloin protects mice from diet-induced non-alcoholic steatohepatitis via activation of Nrf2/HO-1 signaling.
Xu Q; Fan Y; Loor JJ; Liang Y; Lv H; Sun X; Jia H; Xu C
Food Funct; 2021 Jan; 12(2):696-705. PubMed ID: 33410857
[TBL] [Abstract][Full Text] [Related]
12. HWL-088, a new and highly effective FFA1/PPARδ dual agonist, attenuates nonalcoholic steatohepatitis by regulating lipid metabolism, inflammation and fibrosis.
Hu L; Zhou Z; Deng L; Ren Q; Cai Z; Wang B; Li Z; Wang G
J Pharm Pharmacol; 2020 Nov; 72(11):1564-1573. PubMed ID: 32734608
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen-rich water protects against inflammatory bowel disease in mice by inhibiting endoplasmic reticulum stress and promoting heme oxygenase-1 expression.
Shen NY; Bi JB; Zhang JY; Zhang SM; Gu JX; Qu K; Liu C
World J Gastroenterol; 2017 Feb; 23(8):1375-1386. PubMed ID: 28293084
[TBL] [Abstract][Full Text] [Related]
14. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice.
van der Veen JN; Lingrell S; Gao X; Quiroga AD; Takawale A; Armstrong EA; Yager JY; Kassiri Z; Lehner R; Vance DE; Jacobs RL
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G526-38. PubMed ID: 26797396
[TBL] [Abstract][Full Text] [Related]
16. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.
Kodama Y; Kisseleva T; Iwaisako K; Miura K; Taura K; De Minicis S; Osterreicher CH; Schnabl B; Seki E; Brenner DA
Gastroenterology; 2009 Oct; 137(4):1467-1477.e5. PubMed ID: 19549522
[TBL] [Abstract][Full Text] [Related]
17. Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation.
Dattaroy D; Seth RK; Das S; Alhasson F; Chandrashekaran V; Michelotti G; Fan D; Nagarkatti M; Nagarkatti P; Diehl AM; Chatterjee S
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G510-25. PubMed ID: 26718771
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin I
Kumei S; Yuhki KI; Kojima F; Kashiwagi H; Imamichi Y; Okumura T; Narumiya S; Ushikubi F
FASEB J; 2018 May; 32(5):2354-2365. PubMed ID: 29247122
[TBL] [Abstract][Full Text] [Related]
19. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
